Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
NPG-2044 by Novita Pharmaceuticals for Thyroid Cancer: Likelihood of Approval
NPG-2044 is under clinical development by Novita Pharmaceuticals and currently in Phase I for Thyroid Cancer. According to GlobalData, Phase...
Data Insights
NPG-2044 by Novita Pharmaceuticals for Oropharyngeal Cancer: Likelihood of Approval
NPG-2044 is under clinical development by Novita Pharmaceuticals and currently in Phase II for Oropharyngeal Cancer. According to GlobalData, Phase...